Pd34-08 determinants of erectile dysfunction following focal ablative therapy for localised prostate cancer.

Erectile dysfunction (ED) is a recognized adverse effect of focal ablative therapy, although the mechanistic basis to the effects of such treatments on erectile function is largely unknown, with both neuropathic and vascular factors implicated. We aimed to evaluate the determinants of ED following focal ablative therapy using HIFU.

Source: The Journal of Urology - April 1, 2018 Category: Urology & Nephrology Authors: Eoin Dinneen, Neil McCartan, Hashim U. Ahmed, Mark Emberton, Richard Hindley, Clare Allen, Louise Dickinson, Suks Minhas, Tet Yap Tags: Prostate Cancer: Localized: Ablative Therapy II Source Type: research